Recommendations For Cancer Prevention.
Nine of 10 women do not necessity and should not be subjected to genetic testing to ruminate if they are at risk for bosom or ovarian cancer, an influential panel of haleness experts announced Monday. The US Preventive Services Task Force (USPSTF) reaffirmed its antecedent advice from 2005 that only a meagre number of women with a family history of knocker cancer be tested for mutations in the BRCA1 and BRCA2 genes that can raise their cancer risk decanoate. Even then, these women should consult on the test with both their pedigree doctor and a genetic counselor before proceeding with the BRCA genetic test, the panel said.
And "Not all individuals who have encouraging family histories should be tested. It's not at all frank or straightforward," said Dr Virginia Moyer, the strain force's chair. Interest middle women in genetic testing for titty cancer has greatly increased, to a due to Hollywood film star Angelina Jolie's word in May that she underwent a double mastectomy because she carried the BRCA1 mutation treatment. A Harris Interactive/HealthDay question conducted a few months after Jolie's notice found as many as 6 million women in the United States planned to get medical recommendation about having a protection mastectomy or ovary transference because of the actress' belittling decision.
On average, mutations of the BRCA genes can further breast cancer chance between 45 percent to 65 percent, according to the American Cancer Society. The maladjusted is that there are myriad mutations of the BRCA gene. Doctors have identified some mutations that gain boob cancer risk, but there are many more BRCA mutations where the increased danger is either smutty or as yet unknown. "The test is not something that comes back utter or negative.
The test comes back a full lot of different ways, and that has to be interpreted. There are a genus of mutations. Often you get what appears to be a negative study but we call it an 'uninformative' negative because it just doesn't discern you anything. A woman would walk away from that with no idea, but worried, and that's not helpful".
Earlier this month, the genetic testing establishment 23andMe announced it's no longer sacrifice trim information with its home-based accoutrements service after the US Food and Drug Administration warned that the assess is a medical logo that requires government approval. The supplementary task force recommendations will be published online Dec 23, 2013 in the Annals of Internal Medicine. The mission force's judgment carries sombre pressure within the health mindfulness industry.